aruna poojary

About

A clinical Microbiologist and Infection Prevention specialist with research interests in Antimicrobial resistance. I am also a post graduate teacher of Medical Microbiology in India

Employment

• Breach Candy Hospital Laboratory Director
  2023 - Present
• Breach Candy Hospital Trust HOD
  2016 - Present
• Breach Candy Hospital Trust Senior Consultant Microbiologist
  2008 - 2016
• BSES MG Hospital HOD
  2006 - 2008

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (59)

• Epidemiology of rapidly growing mycobacteria and antimicrobial susceptibility profile of Mycobacterium abscessus complex
  Indian Journal of Medical Microbiology 2026 DOI: 10.1016/j.ijmmb.2026.101124
  +Save
• Gap assessment in implementation of Biomedical Waste Management in Health Care Facilities: Nationwide survey in India
  Indian Journal of Medical Microbiology 2025 DOI: 10.1016/j.ijmmb.2025.100947
  +Save
• Towards enhanced selection of antibiotics in a hospital laboratory – development of a rapid electrochemical-based antimicrobial sensitivity test for Urinary Tract Infections.
  2025 DOI: 10.26434/chemrxiv-2025-r6p2m
  +Save
• Analysis of human Metapneumovirus infections in Mumbai (2017–2024)
  Indian Journal of Medical Microbiology 2025 DOI: 10.1016/j.ijmmb.2025.100890
  +Save
• Comparison of rapid antimicrobial susceptibility testing of flash positive blood culture bottles using disk diffusion and automated broth microdilution on VITEK 2 compact with standard methods: Clinical Laboratory Standards Institute (CLSI) protocol
  Indian Journal of Medical Microbiology 2025 DOI: 10.1016/j.ijmmb.2025.100809
  +Save
• Klebsiella pneumoniae urinary tract infection: A multicentric study highlights significant regional variations in antimicrobial susceptibility across India
  IJID Regions 2025 DOI: 10.1016/j.ijregi.2025.100605
  +Save
• Managing Candida auris fungemias: the results of a prospective and international study
  Antimicrobial Agents and Chemotherapy 2025 DOI: 10.1128/aac.00358-25
  +Save
• Mapping antimicrobial susceptibility of community-acquired uropathogenic Escherichia coli across low, middle and high-income countries highlights significant differences: insights for empiric treatment
  IJID Regions 2025 DOI: 10.1016/j.ijregi.2025.100706
  +Save
• Regional variations in antimicrobial susceptibility of community-acquired uropathogenic Escherichia coli in India: Findings of a multicentric study highlighting the importance of local antibiograms
  IJID Regions 2024 DOI: 10.1016/j.ijregi.2024.100370
  +Save
• Understanding clinical outcomes and factors influencing mortality in intensive care unit patients with COVID-19-associated candidemia
  Mycoses 2024 DOI: 10.1111/myc.13687
  +Save